Stay updated on Amivantamab in Esophagogastric Cancer Clinical Trial

Sign up to get notified when there's something new on the Amivantamab in Esophagogastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Amivantamab in Esophagogastric Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    New update entries for 2026-02-12 and 2026-02-17 were added and older 2025 entries removed, updating the study record’s last-update information and QC status.
    Difference
    0.2%
    Check dated 2026-02-18T16:41:20.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.4.2, and previous notices about government funding lapses and the prior v3.4.1 update have been removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-11T11:51:58.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Added a government funding notice about NIH operations and updated the page revision from v3.4.0 to v3.4.1.
    Difference
    0.5%
    Check dated 2026-02-04T10:29:41.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Added a glossary toggle and updated metadata labels (QC criteria status and FEAR Act data). The page revision was updated to v3.4.0.
    Difference
    0.2%
    Check dated 2026-01-28T06:23:53.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The page revision updated from v3.3.3 to v3.3.4; no substantive content changes to the trial details were detected. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:36:32.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Expanded and reorganized the study's site information by adding a generic Locations section and listing sites in California, Massachusetts, New Jersey, and New York. The previous state-specific location blocks were removed.
    Difference
    0.6%
    Check dated 2025-12-23T12:36:16.000Z thumbnail image

Stay in the know with updates to Amivantamab in Esophagogastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Amivantamab in Esophagogastric Cancer Clinical Trial page.